Galit Levi Dunietz

Galit Levi Dunietz

Auto-generated profile, based on publicly available information

Galit Levi Dunietz

Department of Neurology, Division of Sleep Medicine, University of Michigan, Michigan Medicine , Ann Arbor, MI 48108

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2021 in SLEEP
Verified
Journal Article
Open access
PDF file
GDGalit L Dunietz
Galit L Dunietz
RCRonald D Chervin
Ronald D Chervin
JBJames F Burke
James F Burke
ACAlan S Conceicao
Alan S Conceicao
TBTiffany J Braley
Tiffany J Braley
To examine associations between positive airway pressure (PAP) therapy, adherence and incident diagnoses of Alzheimer’s disease (AD), mild cognitive impairment (MCI), and dementia not otherwise specified (DNOS) in older adults. This retrospective study utilized Medicare 5% fee-for-service claims data of 53,321 beneficiaries, aged 65 and older, with an obstructive sleep apnea (OSA) diagnosis prior to 2011. Study participants were evaluated using ICD-9 codes for neurocognitive syndromes (AD [n = 1,057], DNOS [n = 378], and MCI [n = 443]) that were newly identified between 2011 and 2013. PAP treatment was defined as the presence of at least one durable medical equipment (Healthcare Common Procedure Coding System [HCPCS]) code for PAP supplies. PAP adherence was defined as at least two HCPCS codes for PAP equipment, separated by at least 1 month. Logistic regression models, adjusted for demographic and health characteristics, were used to estimate associations between PAP treatment or adherence and new AD, DNOS, and MCI diagnoses. In this sample of Medicare beneficiaries with OSA, 59% were men, 90% were non-Hispanic whites and 62% were younger than 75 years. The majority (78%) of beneficiaries with OSA were prescribed PAP (treated), and 74% showed evidence of adherent PAP use. In adjusted models, PAP treatment was associated with lower odds of incident diagnoses of AD and DNOS (odds ratio [OR] = 0.78, 95% confidence interval [95% CI]: 0.69 to 0.89; and OR = 0.69, 95% CI: 0.55 to 0.85). Lower odds of MCI, approaching statistical significance, were also observed among PAP users (OR = 0.82, 95% CI: 0.66 to 1.02). PAP adherence was associated with lower odds of incident diagnoses of AD (OR = 0.65, 95% CI: 0.56 to 0.76). PAP treatment and adherence are independently associated with lower odds of incident AD diagnoses in older adults. Results suggest that treatment of OSA may reduce the risk of subsequent dementia.

1 April 2015 in Fertility and Sterility
Verified
Journal Article
Closed access
GDGalit Levi Dunietz
Galit Levi Dunietz
CHClaudia Holzman
Claudia Holzman
PMPatricia McKane
Patricia McKane
CLChenxi Li
Chenxi Li
SBSheree Boulet
Sheree Boulet
MDMichael P. Diamond
Michael P. Diamond

15 July 2017 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Open access
PDF file
GDGalit Levi Dunietz
Galit Levi Dunietz
LLLynda D. Lisabeth
Lynda D. Lisabeth
KSKerby Shedden
Kerby Shedden
QSQ. Afifa Shamim-Uzzaman
Q. Afifa Shamim-Uzzaman
ABAlexandra S. Bullough
Alexandra S. Bullough
LOLouise M. O'BRien
Louise M. O'BRien
To estimate the association of restless legs syndrome (RLS) and its frequency with sleep-wake disturbances in pregnancy. A cohort of 1,563 women in their third trimester of pregnancy were recruited from prenatal clinics between March 2007 and December 2010. Demographic, pregnancy, and delivery data were extracted from medical records and sleep information was collected with questionnaires. To diagnose RLS, we used standardized criteria of RLS symptoms and frequency that were developed by the International Restless Legs Study Group. Logistic regression models were constructed to investigate the association of RLS and its frequency with sleep-wake disturbances (poor sleep quality, daytime sleepiness, poor daytime function) and delivery outcomes. Overall 36% of the pregnant women had RLS, and half had moderate to severe symptoms. Compared to women without RLS, those with RLS were more likely to have poor sleep quality (odds ratio [OR] 2.2, 95% confidence interval [CI] 1.7-2.9), poor daytime function (OR 1.9, 95% CI 1.4-2.4), and excessive daytime sleepiness (OR 1.6, 95% CI 1.3-2.0). A dose-response relationship also was evident between RLS frequency and each of the sleep-wake disturbances. There was no evidence for any association between RLS and delivery outcomes. RLS is a significant contributor to poor sleep quality, daytime sleepiness, and poor daytime function, all common and often debilitating conditions in pregnancy. Obstetric health care providers should be aware of these associations and screen women for RLS. A commentary on this article appears in this issue on page 857.

9 May 2018 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
TBTiffany J. Braley
Tiffany J. Braley
GDGalit Levi Dunietz
Galit Levi Dunietz
RCRonald D. Chervin
Ronald D. Chervin
LLLynda D. Lisabeth
Lynda D. Lisabeth
LSLesli E. Skolarus
Lesli E. Skolarus
JBJames F. Burke
James F. Burke

11 January 2017 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
PDF file
GDGl Dunietz
Gl Dunietz
KSKl Strutz
Kl Strutz
CHC Holzman
C Holzman
YTY Tian
Y Tian
DTD Todem
D Todem
JCJm Catov
Jm Catov
Objective: Hypertensive disorders in pregnancy signal an increased risk of cardiovascular disease for women. However, future hypertension risk among pregnant women with moderately elevated blood pressure (BP) is unknown. We examined associations among moderately elevated BP or hypertensive disorders during pregnancy and later prehypertension or hypertension.Design: Longitudinal cohort study.Setting: Five communities in Michigan, USA.Sample: Data are from pregnant women enrolled in the Pregnancy Outcomes and Community Health Study. We included 667 women with gestational BP measurements who participated in the POUCHmoms Study follow‐up 7–15 years later.Methods: Moderately elevated BP was defined as two measures of systolic BP ≥ 120 mmHg or diastolic BP ≥80 mmHg among women without a hypertensive disorder. Weighted multinomial logistic regression models estimated odds of prehypertension or hypertension at follow‐up, adjusted for maternal confounders and time to follow‐up.Main outcome measures: Prehypertension or hypertension.Results: Women meeting the moderately elevated BP criteria (64%) had significantly higher odds of hypertension at follow‐up (adjusted odds ratio 2.6; 95% confidence interval 1.2–5.5). These increased odds were observed for moderately elevated BP first identified before or after 20 weeks of gestation, and for elevated systolic BP alone or combined with elevated diastolic BP.Conclusions: Moderately elevated BP in pregnancy may be a risk factor for future hypertension. Pregnancy offers an opportunity to identify women at risk for hypertension who may not have been identified otherwise.Tweetable Moderately elevated blood pressure in pregnancy may be associated with hypertension later in life.

4 July 2018 in SLEEP
Verified
Journal Article
Closed access
PDF file
GDGalit Levi Dunietz
Galit Levi Dunietz
LSLeslie M Swanson
Leslie M Swanson
EJErica C Jansen
Erica C Jansen
RCRonald D Chervin
Ronald D Chervin
LOLouise M O’bRien
Louise M O’bRien
TBTiffany J Braley
Tiffany J Braley
Pain is common among older adults and negatively impacts functioning. Sleep disturbances and mood disorders, specifically depression and anxiety, are closely associated with pain in older individuals, but the directionality of these associations remains unclear. In this study, we deconstruct long-term temporal effects of two key insomnia symptoms on incident pain into direct and indirect pathways, with focus on depression and anxiety symptoms, within a nationally representative sample. We utilized 2011–2013 data from the National Health and Aging Trends Study, a longitudinal survey of 2239 community-dwelling Medicare beneficiaries. Participants completed annual in-person interviews with assessments of sleep initiation and maintenance; depression, and anxiety (using the Patient Health Questionnaire-2 [PHQ-2] and the Generalized Anxiety Disorder Scale-2 [GAD-2] respectively); and bothersome pain. Causal mediation analysis was applied to examine direct effects of the two insomnia symptoms at baseline on incident pain, and their indirect effects through depression and anxiety symptoms. Almost one-third of the study participants were 69 years old or younger. A similar proportion reported bothersome pain in 2013. The two baseline insomnia symptoms predicted the development of pain. Adjusted analyses suggested that compared to older adults without the two baseline insomnia symptoms, participants with sleep initiation or maintenance difficulties had 24% (95% confidence interval [CI] 2%,51%) and 28% (95% CI 4%,55%) higher odds of incident pain, respectively. Anxiety symptoms partially mediated the relationship between the insomnia symptoms and incident pain, accounting for up to 17% of the total effect, but depressive symptoms did not. These results suggest that improved sleep or anxiety could reduce the risk for future pain.